Remote Monitoring and Home-based Health Care for Treatment of Bone Marrow Transplant Patients

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

October 16, 2022

Study Completion Date

October 16, 2022

Conditions
Bone Marrow Transplant
Interventions
DEVICE

BioIntellisense BioSticker

"This study uses the BioIntellisense BioSticker for RPM, in combination with the BioSync mobile app on participants' mobile phones for data transmission, augmented by use of the BioHub as a backup transmission device. RPM monitoring of device data is accomplished through use of the AlertWatch software system.~BioSticker System TheBioSticker ® System is an FDA-approved remote monitoring wearable device intended for continuous collection of physiological data in home and healthcare settings. This includes heart rate, respiratory rate, skin temperature, estimated body temperature, frequency of severe cough episodes, activity level, sleep duration, body position, degree of incline while sleeping, step count, step symmetry, step strength, and on/off body times and other symptomatic and biometric data. Data are securely transmitted using AES-CTR 128 bit encryption via wireless connection from the device for storage, review, and further analysis."

Trial Locations (1)

80045

University of Colorado Hospital, Aurora

All Listed Sponsors
collaborator

Reimagine Care

UNKNOWN

lead

University of Colorado, Denver

OTHER